Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309227 · ClinicalTrials.gov registry record · NA
Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations
A NA study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04309227: Clinical Trial NA study, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT04309227 is a NA study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04309227, a NA study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The study will investigate the effects of a traditional, high-intensity strengthening program compared to an investigational low-intensity strengthening program that also uses blood flow restriction as part of the training program. Both groups will be compared to a control group, which will receive no training. Measures of strength, function, and patient outcomes will be taken before starting the training, at mid-term, and at the end of the 8-week training program. Additionally, investigators will collect outcome data at 6 and 12 months after completing the program to assess for long term outcomes. The eligible populations are participants with rheumatoid arthritis (RA), osteoarthritis (OA), or myositis. The study will include about 15 participants per group, or 45 people with each diagnosis.
Primary Outcome
Participant's leg strength will be measured by performing a one-repetition maximum lift on both the leg press and leg extension machines. This will be measured at the start of the study, and reassessed with a percent change determined at 4 and 8 weeks. The leg strength measurements will be used to set the weight used during exercise interventions.
Interventions
- OTHER Strength Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2023-08-23 |
| Phase | NA |
Why NCT04309227 stopped before completion
NCT04309227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Strength Training is the first listed.
NCT04309227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04309227 about?
NCT04309227 is a clinical study titled "Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations". The study will investigate the effects of a traditional, high-intensity strengthening program compared to an investigational low-intensity strengthening program that also uses blood flow restriction as part of the training program. Both groups will be compared to a control group, which will receive ...
What is the current status of trial NCT04309227?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-05-01. Estimated completion is 2023-08-23.
What interventions are being tested in trial NCT04309227?
The interventions under investigation include: Strength Training (OTHER).
Who is sponsoring clinical trial NCT04309227?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04309227's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI